STOCK TITAN

Axon (AXON) director receives new restricted stock unit grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GARNREITER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

AXON ENTERPRISE, INC. director Michael Garnreiter reported equity compensation awards rather than open-market trades. On May 29, 2026, he received two grants of common stock totaling several hundred shares at $0.00 per share as part of his director compensation. A footnote explains these are time-vested restricted stock units granted under Axon’s Amended and Restated 2022 Stock Incentive Plan, scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the company’s 2027 Annual Meeting of Shareholders. These transactions reflect routine, plan-based stock awards instead of discretionary buying or selling of Axon shares.

Positive

  • None.

Negative

  • None.
Insider GARNREITER MICHAEL
Role null
Type Security Shares Price Value
Grant/Award Common Stock 611 $0.00 --
Grant/Award Common Stock 47 $0.00 --
Holdings After Transaction: Common Stock — 18,351 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Grant 1 shares 47 shares Common Stock award on May 29, 2026
Grant 2 shares 611 shares Common Stock award on May 29, 2026
Grant price $0.00 per share Equity compensation, not open-market purchase
Grant date May 29, 2026 Date of reported stock awards
restricted stock units financial
"Time-vested restricted stock units granted to the reporting person..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated 2022 Stock Incentive Plan financial
"pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan."
Annual Meeting of Shareholders financial
"the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders."
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GARNREITER MICHAEL

(Last)(First)(Middle)
17800 NORTH 85TH STREET

(Street)
SCOTTSDALE ARIZONA 85255

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AXON ENTERPRISE, INC. [ AXON ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/29/2026A611(1)A$018,351D
Common Stock05/29/2026A47(1)A$018,398D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. The award is scheduled to vest in full on the earlier of the one-year anniversary of the grant date and the date of Axon Enterprise, Inc.'s 2027 Annual Meeting of Shareholders.
Remarks:
/s/ Michael Garnreiter by Isaiah Fields, Attorney-in-Fact06/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Axon (AXON) director Michael Garnreiter report in this Form 4?

Director Michael Garnreiter reported receiving equity compensation in the form of restricted stock units, not market trades. The filing shows stock awards under Axon’s Amended and Restated 2022 Stock Incentive Plan, granted at no cash cost to him as part of board compensation.

How many Axon (AXON) shares were granted to Michael Garnreiter?

The Form 4 lists two stock awards of common shares to Michael Garnreiter. Each entry reflects a grant under Axon’s 2022 Stock Incentive Plan at a price of $0.00 per share, representing routine director equity compensation rather than an open-market purchase.

At what price were the Axon (AXON) stock awards granted to the director?

The reported Axon stock awards were granted at $0.00 per share to director Michael Garnreiter. This zero grant price is typical for restricted stock unit awards, which function as equity-based compensation instead of shares bought in the open market.

When do Michael Garnreiter’s Axon (AXON) restricted stock units vest?

The time-vested restricted stock units are scheduled to vest in full on the earlier of the one-year anniversary of the grant date and Axon’s 2027 Annual Meeting of Shareholders. This creates a clear vesting timeline tied to both time and a future shareholder meeting.

Under what plan were the Axon (AXON) director’s stock units granted?

The filing states the restricted stock units were granted under the Axon Enterprise, Inc. Amended and Restated 2022 Stock Incentive Plan. This plan governs equity-based compensation awards such as time-vested restricted stock units provided to directors and possibly other participants.